Surgical therapy for loco-regional recurrence and distant metastasis of gastric cancer

被引:61
作者
Lehnert, T [1 ]
Rudek, B [1 ]
Buhl, K [1 ]
Golling, M [1 ]
机构
[1] Heidelberg Univ, Dept Surg, Div Surg Oncol, D-69120 Heidelberg, Germany
来源
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY | 2002年 / 28卷 / 04期
关键词
gastric carcinoma; local recurrence; loco-regional recurrence; metastases; treatment;
D O I
10.1053/ejso.2002.1260
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The appearence of distant metastases or local recurrence is assumed to render gastric cancer incurable. However, experience with colorectal cancer has shown that patients with recurrent disease may have a chance for cure, if recurrent or metastatic disease can be completely resected. Since improved imaging allows detection of ever smaller tumour deposits, we have reviewed the pertinent literature to determine the current surgical options for recurrent or metastatic gastric cancer. Metastatic disease or local recurrence is rarely resectable. Tumour recurrence in the remnant stomach after partial gastrectomy can be treated by secondary total gastrectomy and may occasionally result in long-term survival. Other types of local recurrence are generally not amenable to complete resection. The same is true for distant metastases. If, however, distant metasases are technically resectable, 5 year survival of approximately 20% has been documented. Solitary and late appearing metachronous tumours are associated with an improved prognosis, As a consequence resection of distant metastases should be considered, because the risk of metastasectomy is generally low and there is no alternative treatment with a chance for cure. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:455 / 461
页数:7
相关论文
共 73 条
  • [1] Benefits and limits of hepatic resection for gastric metastases[J]. Ambiru, S;Miyazaki, M;Ito, H;Nakagawa, K;Shimizu, H;Yoshidome, H;Shimizu, Y;Nakajima, N. AMERICAN JOURNAL OF SURGERY, 2001(03)
  • [2] BINES SD, 1993, SURGERY, V114, P799
  • [3] Böhner H, 2000, HEPATO-GASTROENTEROL, V47, P1489
  • [4] Extended lymph-node dissection for gastric cancer[J]. Bonenkamp, JJ;Hermans, J;Sasako, M;van de Velde, CJH. NEW ENGLAND JOURNAL OF MEDICINE, 1999(12)
  • [5] Randomized clinical trial of adjuvant mitomycin plus tegafur in patients with resected stage III gastric cancer[J]. Cirera, L;Balil, A;Batiste-Alentorn, E;Tusquets, I;Cardona, T;Arcusa, A;Jolis, L;Saigí, E;Guasch, I;Badia, A;Boleda, M. JOURNAL OF CLINICAL ONCOLOGY, 1999(12)
  • [6] DIENEMANN H, 1995, DT ARTZEBL, V92, P2524
  • [7] DRINGS P, 1995, FORUM DTSCH KREBSGES, V10, P30
  • [8] Resection of liver metastases from a noncolorectal primary: Indications and results based on 147 monocentric patients[J]. Elias, D;de Albuquerque, AC;Eggenspieler, P;Plaud, B;Ducreux, M;Spielmann, M;Theodore, C;Bonvalot, S;Lasser, P. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 1998(05)
  • [9] MITOMYCIN-C AS AN ADJUVANT TREATMENT TO RESECTED GASTRIC-CANCER A 10-YEAR FOLLOW-UP[J]. ESTAPE, J;GRAU, JJ;LCOBENDAS, F;CURTO, J;DANIELS, M;VINOLAS, N;PERA, C. ANNALS OF SURGERY, 1991(03)
  • [10] FASS J, 1998, LANGENBECKS ARCH C S, V2, P1363